We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current 0QF market cap is 42.68B. The company's latest EPS is USD -12.3004 and P/E is -9.86.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 60.21M | 803.4M | 18.47B | 19.26B | 6.85B |
| Operating Income | -545.72M | -763.14M | 13.3B | 9.42B | -4.24B |
| Net Income | -514.02M | -747.1M | 12.2B | 8.36B | -4.71B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.59B | 7.34B | 24.67B | 25.86B | 18.43B |
| Total Liabilities | 414.61M | 4.78B | 10.52B | 6.74B | 4.57B |
| Total Equity | 1.17B | 2.56B | 14.15B | 19.12B | 13.85B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -458.97M | 2.03B | 13.62B | 4.98B | -3.12B |
| Investing | -14.95M | -1.67B | -8.52B | -5.18B | 4.21B |
| Financing | 51.12M | 2.03B | -873M | -3.45B | -1.38B |
| Market Cap | 42.68B |
| Price to Earnings Ratio | -9.86 |
| Price to Sales Ratio | 6.79 |
| Price to Cash Ratio | 15.99 |
| Price to Book Ratio | 3.36 |
| Dividend Yield | - |
| Shares Outstanding | 383.24M |
| Average Volume (1 week) | 10.38k |
| Average Volume (1 Month) | 9.41k |
| 52 Week Change | 2.81% |
| 52 Week High | 156.40 |
| 52 Week Low | 58.76 |
| Spread (Intraday) | 0.76 (0.68%) |
| Company Name | Moderna Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.modernatx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
